CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹376 Cr | ₹300 Cr | ₹242 Cr | ₹21,501 Cr | ₹177 Cr |
What is the latest Consolidated Net Profit of CAPLIN POINT LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹376 Cr |
Mar2023 | ₹300 Cr |
Mar2022 | ₹242 Cr |
Mar2021 | ₹21,501 Cr |
Mar2020 | ₹177 Cr |
How is Consolidated Net Profit of CAPLIN POINT LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹376 Cr | 25.49 | |
Mar2023 | ₹300 Cr | 23.76 | |
Mar2022 | ₹242 Cr | -98.87 | |
Mar2021 | ₹21,501 Cr | 12,077.96 | |
Mar2020 | ₹177 Cr | - |
Compare Consolidated Net Profit of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹15,588.4 Cr | -1.4% | -1.6% | 35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -1.4% |
-1.6% |
35.4% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses